zoladex 10.8 mg implantaatti
astrazeneca oy - goserelin - implantaatti - 10.8 mg - gosereliini
zoladex 3.6 mg implantaatti
astrazeneca oy - goserelin - implantaatti - 3.6 mg - gosereliini
zoladex 10.8 mg implantaatti
paranova oy - goserelini acetas - implantaatti - 10.8 mg - gosereliini
zoladex 3.6 mg implantaatti
paranova oy - goserelini acetas - implantaatti - 3.6 mg - gosereliini
zoladex 10.8 mg implantaatti
orifarm oy - goserelini acetas - implantaatti - 10.8 mg - gosereliini
zoladex 10.8 mg implantaatti
paranova oy - goserelini acetas - implantaatti - 10.8 mg - gosereliini
zoladex 3.6 mg implantaatti
paranova oy - goserelin - implantaatti - 3.6 mg - gosereliini
zoladex 3.6 mg implantaatti
orifarm oy - goserelin - implantaatti - 3.6 mg - gosereliini
firmagon
ferring pharmaceuticals a/s - degareliksia - prostatiset kasvaimet - endokriinihoito - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
leuprorelin sandoz 5 mg implantaatti, esitäytetty ruisku
sandoz a/s - leuprorelin acetate - implantaatti, esitäytetty ruisku - 5 mg - leuproreliini